Vice President Kamala Harris on the campaign trail has frequently touted capping the price of insulin at $35 a month as a ...

Drugmakers blame middlemen known as pharmacy benefit managers for high drug prices. PBMs negotiate drug prices and rebates ...

In recent years, many patients like Mitchell have faced soaring insulin costs. These prices have been exacerbated by pharmacy benefit managers, or PBMs, middlemen between drug manufacturers and ...

Explainer-Who in the US Benefits From $35 Insulin ... Drugmakers blame middlemen known as pharmacy benefit managers for high drug prices. PBMs negotiate drug prices and rebates with manufacturers ...

PBMs have long been seen as the “middlemen” getting in the ... 7 The FTC said that it is not targeting drug manufacturers for rising insulin prices, but it has not ruled out taking legal ...

Ben Hargreaves looks at why insulin ... drug pricing bill fails to take a holistic approach to addressing a system that drives affordability challenges for patients. By taking steps to hold ...

The price of insulin has been a major flashpoint ... Drugmakers blame middlemen known as pharmacy benefit managers for high ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

Kamala Harris and Donald Trump are both pledging to make health care more affordable in the U.S., but have largely different ...

The economy and healthcare are two of the top concerns for voters in this election cycle, and both tickets have promised to ...

Eighty states, cities, counties, school boards and unions have joined litigation consolidated in a New Jersey district court against the three major pharmacy middlemen — CVS Caremark ...

One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...